SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000893750-99-000251
Filing Date
1999-05-21
Accepted
1999-05-21 00:00:00
Documents
1
Group Members
GLAXO GROUP LIMITEDGLAXO WELLCOME INC.GLAXO WELLCOME INTERNATIONAL BVGLAXO WELLCOME PLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A 34285
  Complete submission text file 0000893750-99-000251.txt   36254
Mailing Address 275 ARMAND FRAPPIER BLVD LAVAL QUEBEC E6
Business Address 275 ARMAND-FRAPPIER BLVD LAVAL QUEBEC E6 5146811744
BIOCHEM PHARMA INC (Subject) CIK: 0000867202 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E6 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45089 | Film No.: 99631629
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address SIMPSON THACHER & BARTLETT 99 BISHOPSGATE LONDON X0
Business Address BERKELEY SQUARE LONDON X0 00000
GLAXO WELLCOME PLC (Filed by) CIK: 0000944737 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 1231